Smoking Cessation & Nicotine De-Addiction Products - Global Market Outlook 2018-2023: CAGR is Projected to Grow at 14% - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global Smoking Cessation and Nicotine De-Addiction Products Market - by Type and Geography - Growth, Trends, and Forecast (2018 - 2023)" report has been added to ResearchAndMarkets.com's offering.

The global smoking cessation and nicotine de-addiction products market is expected to register a CAGR of about 14% during the forecast period 2018-2023.

Lifestyle Related Issues Leading to Stress

Of the current 44.5 million smokers in the United States, 70% (31M) claim they would like to quit, 70% of smokers visit a physician yearly, and 46% report an attempt to quit smoking in the past year, which leads to high usage of de-addiction products. Also, this portrays the rising awareness of the population and their willingness to quit smoking.

The rise in awareness is also fueled by government efforts, such as advertisements, and distribution of educational pamphlets, etc. Also, there are non-government organizations working to educate and help people quit smoking are that are engaged dedicatedly to bring the number of smokers down. This will allow the smoking cessation and nicotine de-addiction products market to flourish during the forecast period.

Other factors that will help the market to grow during the forecast period include introduction of new products and reimbursement for smoking cessation therapy.

Notable Highlights

• Lifestyle Related Stress Triggering Smoking
• Asia-Pacific to Show Fastest Growth

Key Development in the Market

• US Food and Drug Administration announced an adult smoking cessation education campaign aimed at encouraging cigarette smokers to quit through messages of support that underscore the health benefits of quitting. These messages will be displayed in and around gas stations and convenience stores - retail locations where smokers face a multitude of triggers and that typically feature cigarette advertisements.

Companies Featured

• Cipla Ltd.
• GlaxoSmithKline PLC
• Imperial Tobacco Company of India Limited
• McNeil AB
• NJOY Inc.
• Novartis International AG
• Pfizer Inc.
• Revolymer PLC
• Takeda Pharmaceutical Co. Ltd.

Key Topics Covered

1. Introduction

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

7. Market Segmentation

8. Competitive Landscape

9. Key Players

10. Future of the Market

For more information about this report visit https://www.researchandmarkets.com/research/vtzp99/smoking_cessation?w=4